文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

免疫接种后焦虑相关不良事件(AEFI):已发表疾病聚集性报告的系统综述

Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness.
PubMed 文献 · Vaccine · 2017-11-29

该系统综述检索7个同行评议数据库,纳入8篇焦虑相关AEFI聚集性报告(每起≥2人),分布于WHO六个区域中除非洲区域外的区域;多数发生在学校儿童中,症状包括头晕、头痛和晕厥,所有受累者均迅速康复,但部分事件导致疫苗接种项目中断,有时长达一年。

要点

  • 焦虑相关AEFI聚集可干扰疫苗接种项目、降低公众信任并影响接种覆盖率。
  • 8起聚集中7起发生在学校儿童中,1起发生在成年军事预备役人员中。
  • 每起报告的所有受累个体均迅速康复,但部分事件造成接种项目中断,有时长达一年。

核心结论

  • 焦虑相关AEFI聚集可干扰疫苗接种项目、降低公众对免疫接种的信任并影响接种覆盖率,恢复公众信心的应对工作可能耗费大量资源。
  • 作者建议:卫生保健人员应接受关于焦虑相关AEFI识别与临床管理的培训;公共卫生当局应制定预防和有效管理焦虑相关AEFI聚集的计划。
  • 作者认为,在信息经社交媒体快速传播的时代,及时管理此类事件可能更为重要。

研究设计与样本

  • 系统文献综述,检索7个同行评议数据库的英文报告,纳入焦虑相关AEFI聚集(≥2人)报告,不限发表时间、病例年龄或疫苗种类。
  • 由两名研究者独立审阅摘要并确定全文审阅文章,从全文提取流行病学与临床信息。
  • 共审阅1472篇摘要,最终识别8篇已发表的聚集性报告。

主要发现

  • 8起聚集分布于WHO六个区域中除非洲区域外的区域。
  • 7起发生在学校环境的儿童中,1起发生在成年军事预备役人员中。
  • 聚集规模从一所学校的7例到多所学校的806例不等。
  • 患者症状包括接种后迅速起病的头晕、头痛和晕厥。
  • 涉及疫苗包括破伤风(2起)、破伤风-白喉(1起)、乙型肝炎(1起)、口服霍乱(1起)、人乳头瘤病毒(1起)和甲型流感(H1N1)pdm09(2起)。

关键数值与推荐

  • 纳入标准为英文报告的焦虑相关AEFI聚集,且每起涉及≥2人。
  • 每起报告的所有受累个体均迅速康复;部分事件出现接种项目中断,有时长达一年。

临床怎么用

  • 作者建议卫生保健人员接受关于焦虑相关AEFI识别与临床管理的培训。
  • 作者建议公共卫生当局制定预防和有效管理焦虑相关AEFI聚集的计划。
  • 作者认为及时管理此类事件在社交媒体时代可能更为重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clusters of anxiety-related adverse events following immunization (AEFI) have been observed in several countries and have disrupted country immunization programs. We conducted a systematic literature review to characterize these clusters, to generate prevention and management guidance for countries. METHODS: We searched seven peer-reviewed databases for English language reports of anxiety-related AEFI clusters (≥2 persons) with pre-specified keywords across 4 categories: symptom term, cluster term, vaccine term, and cluster AEFI phenomenon term/phrase. All relevant reports were included regardless of publication date, case-patient age, or vaccine. Two investigators independently reviewed abstracts and identified articles for full review. Data on epidemiologic/clinical information were extracted from full text review including setting, vaccine implicated, predominant case-patient symptoms, clinical management, community and media response, and outcome/impact on the vaccination program. RESULTS: Of 1472 abstracts reviewed, we identified eight published clusters, from all six World Health Organization (WHO) regions except the African Region. Seven clusters occurred among children in school settings, and one was among adult military reservists. The size and nature of these clusters ranged from 7 patients in one school to 806 patients in multiple schools. Patients' symptoms included dizziness, headache, and fainting with rapid onset after vaccination. Implicated vaccines included tetanus (2), tetanus-diphtheria (1), hepatitis B (1), oral cholera (1), human papillomavirus (1), and influenza A (H1N1)pdm09 (2). In each report, all affected individuals recovered rapidly; however, vaccination program disruption was noted in some instances, sometimes for up to one year. CONCLUSIONS: Anxiety-related AEFI clusters can be disruptive to vaccination programs, reducing public trust in immunizations and impacting vaccination coverage; response efforts to restore public confidence can be resource intensive. Health care providers should have training on recognition and clinical management of anxiety-related AEFI; public health authorities should have plans to prevent and effectively manage anxiety-related AEFI clusters. Prompt management of these occurrences can be even more important in an era of social media, in which information is rapidly spread.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Loharikar A, Suragh TA, MacDonald NE, et al. Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness. Vaccine. 2017. PMID: 29198916. doi:10.1016/j.vaccine.2017.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。